Home

About Us

Pharma-Free CME

Resources by Topic

Resources by Type

Teaching Tools

Drug Industry

Contact Us

RSS NEWS FEED

About Us

PharmedOut is an independent project run by physicians for physicians and other prescribers. Our goals are to:

Document and disseminate information about how pharmaceutical companies influence prescribing

Provide access to unbiased information about drugs

Encourage physicians to choose pharma-free CME

PharmedOut is led by a team of physicians and academics and is contributed to by a diverse group. The Principal Investigator is Adriane Fugh-Berman MD and the Project Manager is Alicia M. Bell MS. Contact PharmedOut

What We Do

We provide lectures at Grand Rounds, meetings, conferences, and medical student events. Invite PharmedOut to speak

We provide access to free, web-based, pharma-free CME – enough for any physician in the U.S to fulfill annual CME requirements without taking industry-funded courses.

PharmedOut CME Modules:

Drug Approval in the U.S. (1.0 CME credit)

Generic Drugs: Prescribing Sensibly (1.0 CME credit)

Links to more than 200 more credits of web-based, free, pharma-free CME

We provide news, information, and resources, including our own slideshows, videos, and other audio-visual material, reading recommendations, resources for unbiased drug information, factsheets, and tools for teaching--including the popular Drug Ad Bingo.

PharmedOut slideshows are open access and available for anyone to see, download, or use (we only ask that you credit us.) How to use our materials

Patient factsheets are available: Fast Facts on Generic Drugs

Our PharmedOut videos provide illuminating glimpses behind the scenes through interviews with former and current industry insiders. Transcripts are available too.

Our news section provides a mix of mainstream and not-so-mainstream news. Subscribe to our RSS feed. Read our PharmedOut publications and media mentions.

PharmedOut is funded through the Attorney General Consumer and Prescriber Education grant program, created as part of a 2004 settlement between Warner-Lambert, a division of Pfizer, Inc., and the Attorneys General of 50 States and the District of Columbia, to settle allegations that Warner-Lambert conducted an unlawful marketing campaign for the drug Neurontin® (gabapentin) that violated state consumer protection laws.

---

Who We Are

Adriane Fugh-Berman, MD

Principal Investigator
Contact Dr. Fugh-Berman


Alicia M. Bell, MS

Project Manager
Contact Ms. Bell

---

Our Videos



Pharma Insider II
Opposition research
(read transcript)

---

Pharma Insider I
Off-label promotion under the radar
(read transcript)

---

The Art of Medical Writing
Pharma's anonymous writers

---

Drug Reps Talk Shop II
Drug reps continue their chat

---

Drug Reps Talk Shop I Selling drugs to docs

---

Director of PharmedOut Explains the Project

---

Zyprexa Drug Rep Tells All Shahram Ahari describes how he sold the drug

---

News

Scientific Fraud May Be More Widespread Than Thought
Poll finds few cases reported Bloomberg

---

Pfizer Ends Direct Funding of Courses
Nonprofit CME unaffected WSJ

---

Drug Makers Say FDA Safety Focus Is Slowing New-Medicine Pipeline
Pulling the plug on “big-sellers” WSJ

---

Senator Slaps GSK Med Ed in Letter to ACCME
Prenatal herpes testing promoted against guidelines MM&M

---

Glaxo Boosts Marketing of Smoking Aids Amid Pfizer Pill's Woes
Free samples go to pilots Bloomberg

---

Weighing the Costs of a CT Scan's Look Inside the Heart
Docs profit from overused test NYT

---

Implant Firms Pay Doctors Millions
51 docs paid a million each Philadelphia Inquirer

---

FDA Panel Urges More Testing for Diabetes Drugs
Ensure heart risks not increased WP

---

Doctors Under the Influence?
Chantix KOLs compare nicotine use to diabetes Businessweek

---

Commentary

Deceptive Market Practices in the Marketplace of Ideas
“Think tanks” distorting health care debate Bioethics Forum

---

You Have Now Been Sampled
Drug rep statements are misleading Pharmagossip

---

Click HERE to read the entire news archives